iframe {
border: 1px solid #e4e5e6;
float:none !important

CEO Mark Capone describes the Myriad Vision and what it means to us. “We want to be the trusted advisor transforming patients lives with our pioneering molecular diagnostics.”

Myriad Genetics at J.P. Morgan Healthcare Conference

Paul J. Diaz, president and chief executive officer, Bryan Riggsbee, chief financial officer, and Dale Muzzey, chief scientific officer, presented at the 41st annual J.P. Morgan (JPM) Healthcare Conference.